Ad Hoc Announcement Pursuant to Art.?53 LR Geneva, Switzerland, January 7, 2026 - Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing ...

In a new study, people who ate more high-fat cheese were less likely to develop dementia. Experts explain the link and reveal ...

ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A nephropathy, address chronic kidney disease in specific ...

The prototype uses a Canon EOS R10 with a Dual Pixel CMOS sensor, which allows every pixel to participate in phase detection.

As of Wednesday, January 07, CytomX Therapeutics, Inc.’s CTMX share price has surged by 6.40%, which has investors questioning if this is right time to sell.

Austin Ryan Lauless, known online as “Cason Fredrickson” or “APOPHIS,” pleaded guilty in September to 13 counts of sexual exploitation of a child, five counts of sex trafficking of a minor, two counts ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation Acquisition builds on Lilly's established capabilities in inflammatory-me ...

Researchers from Carnegie Mellon University's College of Engineering have proposed a new photography method that eliminates the need to choose between focusing on the foreground, midground, ...

Atossa Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing innovative medicines for unmet medical needs, today announced that the U.S. Food and Drug Administration ("FDA") ...

Corcept Therapeutics CORT announced that the FDA has issued a complete response letter (“CRL”) to its new drug application ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...